These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 35314675

  • 1. Extramedullary disease in multiple myeloma: a systematic literature review.
    Bladé J, Beksac M, Caers J, Jurczyszyn A, von Lilienfeld-Toal M, Moreau P, Rasche L, Rosiñol L, Usmani SZ, Zamagni E, Richardson P.
    Blood Cancer J; 2022 Mar 21; 12(3):45. PubMed ID: 35314675
    [Abstract] [Full Text] [Related]

  • 2. Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations.
    Rosiñol L, Beksac M, Zamagni E, Van de Donk NWCJ, Anderson KC, Badros A, Caers J, Cavo M, Dimopoulos MA, Dispenzieri A, Einsele H, Engelhardt M, Fernández de Larrea C, Gahrton G, Gay F, Hájek R, Hungria V, Jurczyszyn A, Kröger N, Kyle RA, Leal da Costa F, Leleu X, Lentzsch S, Mateos MV, Merlini G, Mohty M, Moreau P, Rasche L, Reece D, Sezer O, Sonneveld P, Usmani SZ, Vanderkerken K, Vesole DH, Waage A, Zweegman S, Richardson PG, Bladé J.
    Br J Haematol; 2021 Aug 21; 194(3):496-507. PubMed ID: 33724461
    [Abstract] [Full Text] [Related]

  • 3. Extramedullary multiple myeloma.
    Weinstock M, Ghobrial IM.
    Leuk Lymphoma; 2013 Jun 21; 54(6):1135-41. PubMed ID: 23210572
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Development of extramedullary myeloma in the era of novel agents: no evidence of increased risk with lenalidomide-bortezomib combinations.
    Varga C, Xie W, Laubach J, Ghobrial IM, O'Donnell EK, Weinstock M, Paba-Prada C, Warren D, Maglio ME, Schlossman R, Munshi NC, Raje N, Weller E, Anderson KC, Mitsiades CS, Richardson PG.
    Br J Haematol; 2015 Jun 21; 169(6):843-50. PubMed ID: 26032514
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Soft-tissue plasmacytomas in multiple myeloma: incidence, mechanisms of extramedullary spread, and treatment approach.
    Bladé J, Fernández de Larrea C, Rosiñol L, Cibeira MT, Jiménez R, Powles R.
    J Clin Oncol; 2011 Oct 01; 29(28):3805-12. PubMed ID: 21900099
    [Abstract] [Full Text] [Related]

  • 10. Extramedullary Plasmacytomas of the Oral Cavity: A Case Report and Review of the Literature.
    Bavarian R, Treister NS.
    J Cancer Allied Spec; 2021 Oct 01; 7(2):e417. PubMed ID: 37197217
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A real world multicenter retrospective study on extramedullary disease from Balkan Myeloma Study Group and Barcelona University: analysis of parameters that improve outcome.
    Beksac M, Seval GC, Kanellias N, Coriu D, Rosiñol L, Ozet G, Goranova-Marinova V, Unal A, Bila J, Ozsan H, Ivanaj A, Balić LI, Kastritis E, Bladé J, Dimopoulos MA.
    Haematologica; 2020 Jan 01; 105(1):201-208. PubMed ID: 31278209
    [Abstract] [Full Text] [Related]

  • 15. Extramedullary Disease in Multiple Myeloma.
    Jagosky MH, Usmani SZ.
    Curr Hematol Malig Rep; 2020 Apr 01; 15(2):62-71. PubMed ID: 32198576
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pomalidomide-dexamethasone for treatment of soft-tissue plasmacytomas in patients with relapsed / refractory multiple myeloma.
    Jiménez-Segura R, Granell M, Gironella M, Abella E, García-Guiñón A, Oriol A, Cabezudo E, Clapés V, Soler JA, Escoda L, López-Pardo J, Fernández de Larrea C, Cibeira MT, Tovar N, Isola I, Bladé J, Rosiñol L, GEMMAC (Grup per l l'estudi del mieloma mútiple i l'amiloïdosi de Catalunya).
    Eur J Haematol; 2019 May 01; 102(5):389-394. PubMed ID: 30719772
    [Abstract] [Full Text] [Related]

  • 18. Extramedullary disease in multiple myeloma.
    Bansal R, Rakshit S, Kumar S.
    Blood Cancer J; 2021 Sep 29; 11(9):161. PubMed ID: 34588423
    [Abstract] [Full Text] [Related]

  • 19. Cytogenetic and survival analysis in 315 multiple myeloma patients; five with orbital and eight with extramedullary disease.
    Tucker SM, Zaihra T.
    Orbit; 2023 Dec 29; 42(6):603-611. PubMed ID: 36697375
    [Abstract] [Full Text] [Related]

  • 20. Features of extramedullary disease of multiple myeloma: high frequency of p53 deletion and poor survival: a retrospective single-center study of 834 cases.
    Deng S, Xu Y, An G, Sui W, Zou D, Zhao Y, Qi J, Li F, Hao M, Qiu L.
    Clin Lymphoma Myeloma Leuk; 2015 May 29; 15(5):286-91. PubMed ID: 25640025
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.